JPS55111465A - Prostaglandin i2 analog and its preparation - Google Patents
Prostaglandin i2 analog and its preparationInfo
- Publication number
- JPS55111465A JPS55111465A JP1793579A JP1793579A JPS55111465A JP S55111465 A JPS55111465 A JP S55111465A JP 1793579 A JP1793579 A JP 1793579A JP 1793579 A JP1793579 A JP 1793579A JP S55111465 A JPS55111465 A JP S55111465A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- group
- alkyl group
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003174 prostaglandin I2 derivatives Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 (substituted) phenyl group Chemical group 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 150000001540 azides Chemical class 0.000 abstract 1
- 229940124558 contraceptive agent Drugs 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 230000009027 insemination Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000011906 peptic ulcer disease Diseases 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1793579A JPS55111465A (en) | 1979-02-20 | 1979-02-20 | Prostaglandin i2 analog and its preparation |
AU55625/80A AU540973B2 (en) | 1979-02-20 | 1980-02-18 | 6,9-nitrilo - prostaglandin analogues |
ZA00800921A ZA80921B (en) | 1979-02-20 | 1980-02-18 | 6,9-nitrilo-prostaglandin analogues |
DE19803006032 DE3006032A1 (de) | 1979-02-20 | 1980-02-18 | 6,9-nitrilo-prostaglandin-analoge |
NL8000987A NL8000987A (nl) | 1979-02-20 | 1980-02-18 | 6.9-nitrilo-prostaglandine analoge verbindingen. |
HU80368A HU184239B (en) | 1979-02-20 | 1980-02-18 | Process for preparing 6,9-nitrilo-prostaglandin analogues |
IT19983/80A IT1141221B (it) | 1979-02-20 | 1980-02-18 | Analoghi della 6.9-nitrilo-prostaglandina |
GB8005439A GB2044763B (en) | 1979-02-20 | 1980-02-18 | 6,9 - nitrilo - prostaglandin analogues |
CA000345900A CA1154442A (en) | 1979-02-20 | 1980-02-18 | 6,9-nitrilo-prostaglandin analogues |
IE297/80A IE49512B1 (en) | 1979-02-20 | 1980-02-18 | 6,9-nitrilo-prostaglandin analogues |
BE0/199455A BE881799A (fr) | 1979-02-20 | 1980-02-19 | Analogues de la protaglandine i2 et compositions pharmaceutiques les contenant |
LU82182A LU82182A1 (fr) | 1979-02-20 | 1980-02-19 | Analogues de la prostaglandine i2 et les compositions pharmaceutiques les contenant |
CH133580A CH646152A5 (fr) | 1979-02-20 | 1980-02-19 | Analogues de la prostaglandine et compositions pharmaceutiques les contenant. |
US06/122,704 US4313954A (en) | 1979-02-20 | 1980-02-19 | 6,9-Nitrilo-prostaglandin analogues |
FR8003580A FR2449680A1 (fr) | 1979-02-20 | 1980-02-19 | Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1793579A JPS55111465A (en) | 1979-02-20 | 1979-02-20 | Prostaglandin i2 analog and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55111465A true JPS55111465A (en) | 1980-08-28 |
JPS6228134B2 JPS6228134B2 (ja) | 1987-06-18 |
Family
ID=11957625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1793579A Granted JPS55111465A (en) | 1979-02-20 | 1979-02-20 | Prostaglandin i2 analog and its preparation |
Country Status (15)
Country | Link |
---|---|
US (1) | US4313954A (ja) |
JP (1) | JPS55111465A (ja) |
AU (1) | AU540973B2 (ja) |
BE (1) | BE881799A (ja) |
CA (1) | CA1154442A (ja) |
CH (1) | CH646152A5 (ja) |
DE (1) | DE3006032A1 (ja) |
FR (1) | FR2449680A1 (ja) |
GB (1) | GB2044763B (ja) |
HU (1) | HU184239B (ja) |
IE (1) | IE49512B1 (ja) |
IT (1) | IT1141221B (ja) |
LU (1) | LU82182A1 (ja) |
NL (1) | NL8000987A (ja) |
ZA (1) | ZA80921B (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58203911A (ja) * | 1982-05-25 | 1983-11-28 | Ono Pharmaceut Co Ltd | プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤 |
JPS6130519A (ja) * | 1984-07-23 | 1986-02-12 | Dainippon Pharmaceut Co Ltd | 脳神経細胞の酸素欠乏性疾患治療剤 |
DE102014200866A1 (de) * | 2014-01-17 | 2015-07-23 | Iwa - F. Riehle Gmbh & Co Kg | Vorrichtung zur Ermittlung einer zu spritzenden Insulinmenge bei Diabetes-Patienten |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS549265A (en) * | 1977-06-17 | 1979-01-24 | Upjohn Co | Composition and method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54125653A (en) * | 1978-03-18 | 1979-09-29 | Ono Pharmaceut Co Ltd | Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent |
US4211706A (en) * | 1978-10-13 | 1980-07-08 | The Upjohn Company | 9-Deoxy-9α,6-nitrilo or 6,9α-imino-17,18-didehydro-PGF compounds |
-
1979
- 1979-02-20 JP JP1793579A patent/JPS55111465A/ja active Granted
-
1980
- 1980-02-18 CA CA000345900A patent/CA1154442A/en not_active Expired
- 1980-02-18 IE IE297/80A patent/IE49512B1/en unknown
- 1980-02-18 GB GB8005439A patent/GB2044763B/en not_active Expired
- 1980-02-18 NL NL8000987A patent/NL8000987A/nl not_active Application Discontinuation
- 1980-02-18 HU HU80368A patent/HU184239B/hu not_active IP Right Cessation
- 1980-02-18 IT IT19983/80A patent/IT1141221B/it active
- 1980-02-18 ZA ZA00800921A patent/ZA80921B/xx unknown
- 1980-02-18 DE DE19803006032 patent/DE3006032A1/de active Granted
- 1980-02-18 AU AU55625/80A patent/AU540973B2/en not_active Ceased
- 1980-02-19 CH CH133580A patent/CH646152A5/fr not_active IP Right Cessation
- 1980-02-19 US US06/122,704 patent/US4313954A/en not_active Expired - Lifetime
- 1980-02-19 LU LU82182A patent/LU82182A1/fr unknown
- 1980-02-19 FR FR8003580A patent/FR2449680A1/fr active Granted
- 1980-02-19 BE BE0/199455A patent/BE881799A/fr not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS549265A (en) * | 1977-06-17 | 1979-01-24 | Upjohn Co | Composition and method |
Also Published As
Publication number | Publication date |
---|---|
HU184239B (en) | 1984-07-30 |
US4313954A (en) | 1982-02-02 |
IT8019983A0 (it) | 1980-02-18 |
IE800297L (en) | 1980-08-20 |
DE3006032A1 (de) | 1980-08-28 |
FR2449680A1 (fr) | 1980-09-19 |
GB2044763B (en) | 1983-02-23 |
DE3006032C2 (ja) | 1988-03-17 |
LU82182A1 (fr) | 1980-09-24 |
AU5562580A (en) | 1980-08-28 |
AU540973B2 (en) | 1984-12-13 |
NL8000987A (nl) | 1980-08-22 |
ZA80921B (en) | 1981-02-25 |
CA1154442A (en) | 1983-09-27 |
GB2044763A (en) | 1980-10-22 |
FR2449680B1 (ja) | 1983-04-15 |
IE49512B1 (en) | 1985-10-16 |
BE881799A (fr) | 1980-08-19 |
CH646152A5 (fr) | 1984-11-15 |
IT1141221B (it) | 1986-10-01 |
JPS6228134B2 (ja) | 1987-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4158667A (en) | 6-Keto PGF analogs | |
ZA88317B (en) | New 11-aryl steroid derivatives | |
JPS56158760A (en) | Prostaglandin analog compound, its preparation and drug composition containing the same | |
US4013695A (en) | 4,4,5,5-Tetradehydro-PGE1 analogs | |
JPS51149247A (en) | Prostaglandin analogues, process for their preparation and drug compos itions containing them as effective ingredients | |
JPS55111465A (en) | Prostaglandin i2 analog and its preparation | |
JPS5395958A (en) | Prostaglandin analogues and process for their preparation | |
US3904679A (en) | 15-Methyl and 15-ethyl prostaglandin F{HD 2{331 {0 {B analogs | |
IL59479A0 (en) | New 7-alkylated steroid derivatives,process for preparing them, their use as a medicament and the pharmaceutical compositions containing them | |
US4292445A (en) | Amide and sulfonamide derivatives of 2-decarboxy-2-aminomethyl-PG-type compounds | |
JPS5419946A (en) | Prostaglandin analog compound and their preparation | |
GB1430995A (en) | 13-cis-prostaglandin derivatives and their preparation | |
GB1473670A (en) | Process for the manufacture of prostaglandin-f2a and analogues thereof | |
JPS5414998A (en) | Prostaglandin i2 analog and its preparation | |
JPS5589297A (en) | Prostaglandin derivative, its preparation and its drug | |
JPS5236646A (en) | Process for preparation of prostaglandin derivatives and pharmceutical composition containing the compounds as effectual components | |
US4235997A (en) | 6-Alkoxy-ω-aryl-PGI1 compounds | |
JPS5452069A (en) | Prostaglandin i2 analog compound and its preparation | |
JPS5430147A (en) | Prostaglandin i, analogues and their preparation | |
US4255355A (en) | 2-Decarboxy-2-aminomethyl-6-keto-PGE1 compounds | |
JPS5476554A (en) | Intermediate of prostaglandin analog and its production | |
IE812843L (en) | Estra-4,9-dienes | |
JPS53127441A (en) | Prostaglandin-like compounds and their preparation | |
JPS51122040A (en) | A process for preparing prostaglandin analogues | |
US4289877A (en) | 2-Decarboxy-2-tetrazolyl-9-deoxy-5,9α-epoxy-4,5-cis-17,18-tetradehydro-PGF1 compounds |